Trial Profile
A phase II study investigating the effect of combination of bevacizumab with gemcitabine and oxaliplatin in platinum-resistant recurrent ovarian cancer patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Dec 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Gemcitabine; Oxaliplatin
- Indications Ovarian cancer
- Focus Therapeutic Use
- 05 Dec 2015 New trial record